WILMINGTON, MA — Implant Sciences Corporation, a leading manufacturer of explosives trace detection (ETD) solutions for Department of Homeland Security (DHS) applications, announced Tuesday that it was awarded a Standing Offer from the Canadian Air Transport Security Authority (CATSA) for up to 340 of its industry-leading QS-B220 desktop explosives trace detectors. These systems are to be deployed over the course of approximately the next two years to Canadian airports for passenger and baggage screening.
Implant Sciences’ ETDs have been deployed to more than 160 airports over the last year. This order is in addition to the QS-B220 win last year of CATSA’s competitive bid for 112 ETDs.
“Our robust systems, continue to be deployed in airports globally, deliver highly accurate and effective screening to the traveling public,” stated Todd Swearingen, General Manager, Americas for Implant Sciences. “We pride ourselves in supporting the mission of safeguarding passengers around the world, and we are excited to have been selected again by CATSA.”
“Our goal, as the pioneers of non-rad ETD, is to advance our products to meet the evolving needs of our customers and to surpass the performance and detection limitations of legacy trace detectors that are currently fielded,” added Dr. Darryl Jones, Implant Sciences’ Executive Vice President. “Implant Sciences’ market share capture continues in North America and in the rest of the world. High-profile customers, like CATSA, repeatedly selecting our ETD solutions is the strongest endorsement we can receive.”
About the QS-B220 Desktop Explosives Trace Detector
The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.
About Implant Sciences
Implant Sciences is a leader in developing and manufacturing advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs. The Company’s team of dedicated trace detection experts has developed proprietary technologies used in its commercial products, thousands of which have been sold across more than 70 countries worldwide. The Company’s ETDs have received approvals and certifications from several international regulatory agencies including the TSA in the U.S., ECAC in Europe, CAAC and the Ministry of Public Safety in China, Russia FSB, STAC in France, and the German Ministry of the Interior. It has also received the 2015 GSN Airport/Seaport/Border Security Award for “Best Security Checkpoint”. For further details on the Company and its products, please visit the Company’s website at http://www.implantsciences.com.
(NOTE: The above press release is from Implant Sciences via PRNewswire.)
Like Wilmington Apple on Facebook. Follow Wilmington Apple on Twitter. Subscribe to Wilmington Apple’s daily email newsletter HERE. Got a comment, question, photo, press release, or news tip? Email wilmingtonapple@gmail.com.
Wilmington Apple 